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ABSTRACT 
10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-carbaldehyde (2) was prepared by 
Vilsmeier-Haack reaction of 3-amino-2-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one (1). Reaction of 
carbaldehyde derivative 2 with malononitrile afforded arylidene malononitrile 3. Cyclization of the latter compound with 
thiourea yielded pyrimidinethione 4. Interaction of carbaldehyde derivative 2 in presence of thiourea with keto- compounds 
such as ethyl acetoacetate, or acetylacetone, or dimedone or ethyl cyanoacetate gave pyrimidine derivatives 5-8. 
Hydrazinolysis of carbaldehyde derivative 2 gave the hydrazone 9. Reaction of the latter with phenyl isothiocyanate 
afforded thiosemicarbazone 10, which underwent cyclization with oxalyl chloride to give thioxoimidazolidinedione 11. 
Condensation of compound 2 with thiosemicarbazide furnished thiosemicarbazone derivative 12. Reaction of compound 2 
with aminopyrazolone in the presence of an acid and/or a base afforded pyrazolones 13 and 14. Treatment of 
carbaldehyde derivative 2 with cyanoacetohydrazide gave acrylohydrazide 15. Interaction of the latter with carbon disulfide 
yielded mercaptooxadiazole 16.  Condensation of compound 2 with acetylpyridazinone 17 produced chalcone 18. 
Reaction of  compound 18 with malononitrile in pyridine gave cyanopyran 19, while its reaction with malononitrile in 
presence of ammonium acetate in ethanol yielded cyanopyridine 20. Structures of the newly synthesized products have 
been deduced on the basis of elemental analysis and spectral data. The synthesized compounds were screened for their 
antimicrobial activity.  
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INTRODUCTION  
A literature survey has revealed the diversified biological and pharmacological significance of several nitrogen 
and sulphur heterocycles. This aspect has been drawing the attention of many researchers towards exploiting the 
biological importance of various heterocyclic compounds and to establish the relationship between their biological, 
pharmacological potency and structural features [1]. Heterocycles containing the thienopyrimidine moiety are of interest 
because of their interesting pharmacological and biological activities [2-7]. Thus, over the last two decades many 
thienopyrimidines have been found to exhibit a variety of pronounced activities, for example, as anti-inflammatory [4,8], 
antimicrobial [4,9], antiviral [10], and analgesic agents [8, 11]. Some thienopyrimidine derivatives showed good antitumor 
activity [12-14]. Consequently, thienopyrimidines have become a well-sought privileged class of compounds in drug 
discovery programs. In view of these reports and in continuation of our work on biologically active nitrogen and sulfur 
heterocycles [15-18], we have synthesized some novel thienopyrimidines and evaluated them for their antimicrobial 
properties.   
RESULTS AND DISCUSSION    
The key intermediate 10-oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-
carbaldehyde (2) was prepared by Vilsmeier-Haack reaction of 3-amino-2-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d] 
pyrimidin-4(3H)-one (1) [19]
 
(Scheme 1). The IR spectrum of compound 2 exhibited characteristic absorption bands at 
3231 (NH), 3085 (CHarom.), 2940 (CHaliph.), 1716 (C=Oformyl), 1648 (C=Opyrimidinone), 1605 (C=N) and 1561 cm
-1
 (C=C). Also, 
its 
1
H NMR spectrum showed exchangeable signal at δ 9.82 ppm assigned to the NH proton, in addition to signal at δ 9.77 
ppm indicating the presence of aldehyde proton. The mass spectrum of compound 2 showed the molecular ion peak and 
the base peak at m/z 273 which is coincident with the molecular weight (273.31) as supports the identity of the structure. 
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Scheme 1. Synthesis of formyl derivative 2. 
 
Compound 2 was allowed to react with malononitrile in DMF containing few drops of piperidine afforded the 
arylidene malononitrile derivative 3. Treatment of 3 with thiourea in DMF containing few drops of piperidine resulted in the 
formation of the thione derivative 4. This latter compound could be obtained directly by the reaction of 2 with malononitrile 
and thiourea in presence of a base. Our study was extended to the reaction of 2 with a variety of keto- compounds in 
presence of thiourea in order to synthesize new compounds have a pyrimidine moiety. For example, formyl derivative 2 
reacted with ethyl acetoacetate, or acetylacetone, or dimedone or ethyl cyanoacetate in presence of thiourea to afford 
compounds 5, 6, 7 and 8, respectively (Scheme 2).   
The structures of compounds 3 and 4 were characterized from their spectroscopic as well as elemental analytical 
data. Thus, the IR spectrum of compound 3 revealed absorption bands at 1685, 2210 and 3447 cm
−1
 corresponding to 
C=O, C≡N and NH functions, respectively. Its 
1
H NMR spectrum showed the presence of the cyclohexane ring methylene 
protons at δ 1.72–1.74, 2.70 and 2.83  and a D2O-exchangeable signal at δ 9.71 due to NH proton. The IR spectrum of 
compound 4 showed absorption bands at 1198, 1653, 2209 and 3420-3200 cm
−1
 corresponding to C=S, C=O, C≡N, NH 
and NH2 functions, respectively. Its 
1
H NMR spectrum revealed a D2O-exchangeable signal at δ 8.79 ppm corresponding 
to three NH protons in addition to a D2O-exchangeable signal at δ 3.57 due to NH2 protons.  
The structures of compounds 5-8 were confirmed on the basis of spectroscopic data and elemental analyses. 
The 
1
H NMR spectrum of compound 5 showed a triplet signal at δ 1.27 (J = 6.9 Hz) corresponding to CH3 protons, a 
quartet signal at δ 4.20 (J = 6.9 Hz) due to CH2 protons, a doublet signal at δ 5.30 corresponding to CH-4 proton, and two 
D2O-exchangeable signals at δ 6.90 and 7.07 due two NH protons. The mass spectrum of compound 7 revealed the 
molecular ion peak at m/z 453 corresponding to the molecular formula C22H23N5O2S2, which agree well with the molecular 
weight (453.58) and supports the identity of the structure. The IR spectrum of compound 8 showed absorption bands at 
1701, 1678, 2220, 2380 and 3424 cm
-1
 corresponding to two C=O groups, C≡N, SH and two NH functions, respectively. 
The 
1
H NMR spectrum of the same compound revealed a D2O-exchangeable signal at δ 1.23 due to SH proton and two 
D2O-exchangeable signals at δ 8.39 and 8.58 due to two NH protons. 
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Scheme 2. Formation of pyrimidine derivatives 4-8. 
 
Treatment of 2 with hydrazine hydrate in presence of triethylamine as a catalyst in DMF gave the corresponding 
hydrazone 9, which was allowed to react with phenyl isothiocyanate in DMF containing few drops of piperidine to give the 
thiosemicarbazone derivative 10. Heterocyclization of compound 10 with oxalyl chloride in boiling DMF containing few 
drops of triethylamine produced the novel thioxoimidazolidinedione derivative 11 (Scheme 3). Also, condensation of  2 
with thiosemicarbazide in refluxing glacial acetic acid afforded the corresponding thiosemicarbazone 12 (Scheme 3). The 
structures of the products were determined from spectroscopic as well as elemental analytical data. Thus, IR spectrum of 
compound 9 exhibited characteristic absorption bands at 3340-3197 (NH2, NH), 1670 (C=Opyrimidinone) and 1607 cm
-1
 
(C=N). Also, its 
1
H NMR spectrum showed D2O-exchangeable signals at δ 3.36 and 11.51 ppm assigned to the NH2 and 
NH protons, respectively. The 
1
H NMR spectra of compound 10 showed characteristic D2O-exchangeable signals at δ 
8.66, 8.88 and 12.12 ppm assigned to three N-hydrogens. The IR spectrum of compound 12 showed absorption bands at 
3445-3300 cm
-1
 due to NH2 and NH functions. Its 
1
H NMR spectrum showed two D2O-exchangeable signals at δ 11.22, 
8.36 ppm corresponding to two NH protons, D2O-exchangeable signal at δ 3.47 ppm due to NH2 protons and a singlet 
signal at δ 9.77 ppm corresponding to CH=N. 
ISSN 2321-807X 
 
584 | P a g e                                                    O c t o b e r  2 9 ,  2 0 1 3 
DMF/pip.
N
2
H
4
.H
2
O
DMF/TEA
PhNCS
Ar
N
N
H
N
H
S
Ph
NN
S N
H
O
NH
2
N
H
NH
2
S
Ar
N
N
H
NH
2
S
Ar
N
NH
2
Ar
N
N N
S
Ph
OO
DMF/TEA
2
Ar=
=
12
910
AcOH
11
(COCl)2
 
Scheme 3. Synthesis of thioxoimidazolidinedione 11 and thiosemicarbazone 12. 
 
The reaction of formyl derivative 2 with 5-amino-2,4-dihydro-3-pyrazol-3-one in refluxing ethanol in the presence 
of a catalytic amount of glacial acetic acid produced pyrazolyl derivative 13. While, the reaction of compound 2 with 5-
amino-2,4-dihydro-3-pyrazol-3-one in refluxing ethanol in the presence of a catalytic amount of triethylamine gave 
pyrazolylidene derivative 14. Further, treatment of 2 with cyanoacetohydrazide in presence of triethylamine as a catalyst in 
ethanol afforded acrylohydrazide derivative 15. Fusion of 15 with no solvent resulted in the formation of pyrazolylidene 
derivative 14. Furthermore, the interaction of 15 with carbon disulfide in ethanolic KOH solution under reflux yielded the 
corresponding oxadiazole 16 (Scheme 4). The structures of the products were characterized from their spectroscopic as 
well as elemental analytical data. Thus, the IR spectrum of compound 13 revealed absorption bands at 1660 and 3373  
cm
-1
 corresponding to two C=O groups and two NH functions, respectively. Its 
1
H NMR spectrum showed two D2O-
exchangeable signals at δ 8.14 and 9.52 ppm corresponding to two NH protons, in addition to a singlet signal at δ 4.83 
ppm assigned to the methylene protons. The 
1
H NMR spectrum of compound 14 showed an exchangeable signal at δ 
5.22 ppm attributed to the NH2 protons, while the 
1
H NMR spectrum of compound 15 showed characteristic D2O-
exchangeable signals at δ 9.97 and 11.24 ppm assigned to two N-hydrogens and D2O-exchangeable signal at δ 5.63 ppm 
due to NH2 protons, in addition to singlet signal at δ 7.21 ppm assigned to the methine proton. 
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Scheme 4. Formation of pyrazolone derivatives 13, 14 and oxadiazole 16. 
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The synthesis of cyanopyran 19 and cyanopyridine 20 from chalcone 18 was performed as shown in Scheme 5. 
In the initial step, chalcone 18 was synthesized by condensing formyl derivative 2 with 4-acetyl-5,6-diphenylpyridazin-
3(2H)-one (17) [20], in presence of a catalytic amount of a base. Finally, cyanopyran 19 was synthesized by reacting 
chalcone 18 with malononitrile in pyridine, while cyanopyridine 20 was synthesized by reacting chalcone 18 with 
malononitrile in presence of ammonium acetate in ethanol (Scheme 5). The 
1
H NMR spectra of compound 18 showed 
characteristic signals at δ 7.10 and 7.66 ppm assigned to ethylienic protons. Also, the mass spectra of compound 18 
revealed the molecular ion peaks at m/z 545 which agree well with the molecular weight for compound 18. The 
1
H NMR 
spectrum of compound 19 showed a characteristic doublet at δ 7.94 and 8.41 ppm attributed to pyran-H4 and -H5, 
respectively, in addition to an exchangeable signal at δ 4.45 ppm assigned to the NH2 protons, while the 
1
H NMR 
spectrum of compound 20 showed an exchangeable signal at δ 5.40 ppm attributed to the NH2 protons. 
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Scheme 5. Synthetic pathway for the preparation of cyanopyran 19 and cyanopyridine 20. 
 
Biological Activities 
The standardized disc agar diffusion method [21] was followed to determine the activity of the synthesized 
compounds against  the sensitive organisms Staphylococcus aureus and Bacillus subtilis as Gram-positive bacteria, 
Salmonella typhimurium and Escherichia coli as Gram-negative bacteria and Candida albicans as fungus strain. The 
compounds were dissolved in DMSO which has no inhibition activity to get concentration of 100 µg mL
-1
. The test was 
performed on medium potato dextrose agars (PDA) which contain infusion of 200 g potatoes, 6 g dextrose and 15 g agar 
[22]. Uniform size filter paper disks (3 disks per compound) were impregnated by equal volume (10 µL) from the specific 
concentration of dissolved tested compounds and carefully placed on inoculated agar surface. After incubation for 36 h at 
27 °C in the case of bacteria and for 48 h at 24 °C in the case of fungi, inhibition of the organisms was measured and used 
to calculate mean of inhibition zones. 
 The synthesized polyfused systems exhibited lower to mild antimicrobial activity. Thus, the synthesized 
compounds may be considered promising for the development of new antimicrobial agents as depicted in Table 1. 
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Table 1.  The antimicrobial activity of some synthesized compounds: 
 
*  = Calculate from 3 values. -  = No effect. L: Low activity = Mean of zone diameter ≤ 1/3 of mean zone diameter of 
control. I: Intermediate activity = Mean of zone diameter ≤ 2/3 of mean zone diameter of control. H: High activity = Mean of 
zone diameter > 2/3 of mean zone diameter of control. #: Chloramphenicol in the case of Gram-positive bacteria, 
Cephalothin in the case of Gram-negative bacteria and cycloheximide in the case of fungi. 
 
EXPERIMENTAL PROCEDURE 
 Melting points are uncorrected and were recorded in open capillary tubes on a Stuart SMP3 melting point apparatus. IR 
spectra were recorded on a FT-IR Bruker Vector 22 spectrophotometer using a KBr wafer technique. The 
1
HNMR spectra 
was recorded in DMSO-d6 on a Gemini spectrometer (300MHz) and the chemical shift in δ downfield from TMS as an 
internal standard. Elemental microanalyses were performed at the Main Laboratories of the War Chemical. Mass spectra 
were obtained using gas chromatography GCMS qp-2010 and on a Shimadzu instrument mass spectrometer (70 eV) at 
the Cairo University Microanalytical Center. 3-Amino-2-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one 
(1) was prepared according to the reported method [19].  
10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-carbaldehyde (2) 
                    To dry dimethylformamide (0.5 mL) in a three necked flask, POCl3 (0.15 mL) was added slowly with intensive 
stirring at 0 
o
C. The solution of compound 1 (0.235 g, 0.001 mol) in DMF (0.5 mL) was then slowly added under stirring at 
50 
o
C. The stirring was continued for 2 hrs at 55-60 
o
C. After cooling, the reaction mixture was poured onto ice/water. The 
precipitated solid was filtered off, washed with water, air dried and crystallized from DMF to give compound 2 as yellow 
crystals, yield 68%, mp 283-285 °C. IR (KBr) νmax/cm
-1
: 3231 (NH), 3085 (CHarom.), 2940 (CHaliph.), 1716 (C=Oformyl), 1648 
(C=Opyrimidinone), 1605 (C=N), 1561 (C=C); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.77-1.78 (m, 4H, 2CH2), 2.72 (t, 2H, 
CH2), 2.92 (t, 2H, CH2), 8.44 (s, 1H, pyrazole-H2), 9.77 (s, 1H, CHO), 9.82 (s, 1H, NH exchangeable with D2O); MS m/z 
 
Mean* of zone diameter , nearest whole mm. 
Gram - positive bacteria Gram - negative bacteria Fungi 
Compound 
No. 
Staphylococcus 
aureus 
(ATCC 25923) 
Bacillus subtilis  
(ATCC 6635) 
Salmonella 
typhimurium 
(ATCC 14028) 
Escherichia 
coli  
(ATCC 25922) 
Candida albicans 
(ATCC 10231) 
 
1 
 mg/ml 
0.5 
mg/ml 
1 
mg/ml 
0.5 
 mg/ml 
1 
 mg/ml 
0.5 
mg/ml 
1 
mg/ml 
0.5 
mg/ml 
1 
 mg/ml 
0.5 
mg/ml 
1 - - 8 L 8 L 10 L 8 L - - - - 
2 10 L 9 L 20 I 16 I 11 L 9 L - - 22 I 16 I 
3 - - - - 16 I  14 I - - 21 I 16 I 
4 - - - - - - - - 15 I 10 I 
5 - - 13 I 8 L - - - - - - 
6 - - 21 I 16 I - - - - 21 I 16 I 
7 - - 14 I 8 L - - - - 17 I 12 I 
8 - - 12 I 8 L 9 L  7 L - - 17 I 14 I 
9 - - 18 I 16 I - - - - - - 
10 - -  11 L 8 L - - - - - - 
12 - - 13 I 9 L - - - -   24 H 16 I 
13 - - 9 L 7 L 9 L 7 L - - - - 
14 - - 9 L 7 L 8 L 7 L 8 L 8 L 8 L 7 L 
15 - - 23 I 17 I - - - - 12 I 10 I 
18 - - 18 I 15 I - - - - 20 I 14 I 
19 - - - - - - - - 19 I 16 I 
Control # 35 26 35 25 36 28 38 27 35 28 
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(%): 275 [M
+
+2] (7), 274 [M
+
+1] (18), 273 [M
+
] (100), 245 (31), 217 (10), 91 (7), 77 (7), 52 (8); Anal. Calcd for C13H11N3O2S 
(273.31): C, 57.13; H, 4.06; N, 15.37; S, 11.73. Found C, 57.12; H, 4.06; N, 15.36; S, 11.70%. 
 [(10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-3-yl)-methylene]malononitrile (3) 
A mixture of compound 2 (0.273 g, 0.001 mol) and malnonitile  (0.066 g, 0.001 mol) in DMF (10 mL) containing 
catalytic amount of piperidine was heated under reflux for 3 h. After cooling, the reaction mixture was poured onto 
ice/water and neutralized with conc. HCl. The precipitated solid was filtered off, washed with water, air dried and 
crystallized from dioxane to give compound 3 as brown crystals, yield 75%, mp 168-170 ºC. IR (KBr) νmax/cm
-1
: 3447 (NH), 
3062 (CHarom.), 2936 (CHaliph.), 2210, 2195 (2 C≡N), 1685 (C=O), 1636 (C=N), 1559 (C=C); 
1
H NMR spectrum (300 MHz, 
DMSO-d6) δ 1.72-1.74 (m, 4H, 2CH2), 2.70 (t, 2H, CH2), 2.83 (t, 2H, CH2), 7.11 (s, 1H, CH=), 8.06 (s, 1H, pyrazole-H2), 
9.71 (s, 1H, NH exchangeable with D2O); MS m/z (%): 322 [M+1] (19), 321 [M
+
] (38), 320 [M
+
-1] (27), 294 (23), 267 (23), 
70 (65), 100 (27), 57 (100); Anal. Calcd for C16H11N5OS (321.35): C, 59.80; H, 3.45; N, 21.79; S, 9.98. Found C, 59.80; H, 
3.44; N, 21.80; S, 9.98%. 
6-Amino-4-(10-oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-3-yl)-2-thioxo-1,2,3,4-
tetrahydropyrimidine-5-carbonirile (4)  
Method A. A mixture of compound 3 (0.321 g, 0.001 mol) and thiourea (0.076 g, 0.001 mol) in DMF (10 mL) 
containing catalytic amount of piperidine was heated under reflux for 3h. After cooling, the solid obtained was filtered off, 
washed with water, air dried and crystallized from DMF/EtOH to give compound 4 as brown crystals, yield 75%, mp > 300 
°C. IR (KBr) νmax/cm
-1
: 3420-3200 (NH2, NH), 2928 (CHaliph.), 2209 (C≡N), 1653 (C=O), 1636 (C=N), 1559 (C=C), 1198 
(C=S); 
1
H NMR spectrum 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.78-1.80 (m, 4H, 2CH2), 2.71 (t, 2H, CH2), 2.92 (t, 
2H, CH2), 3.57 (bs, 2H, NH2 exchangeable with D2O), 5.24 (d, 1H, pyrimidine-H4), 8.33 (s, 1H, pyrazole-H2), 8.79 (s, 3H, 
3NH exchangeable with D2O); MS m/z (%): 398 [M
+
+1] (61), 397 [M
+
] (64), 355 (100), 296 (81), 271 (98), 240 (90), 151 
(81), 76 (71); Anal. Calcd for C17H15N7OS2 (397.47): C, 51.37; H, 3.80; N, 24.67; S, 16.13. Found C, 51.36; H, 3.80; N, 
24.68; S, 16.12%. 
Method B. A mixture of compound 2 (0.273 g, 0.001 mol), thiourea (0.076 g, 0.001 mol) and malnonitile (0.066 g, 
0.001 mol) in DMF (10 mL) containing catalytic amount of piperidine was heated under reflux for 3 h. After cooling, the 
reaction mixture was poured onto ice/water and neutralized with conc. HCl. The precipitated solid was filtered off, washed 
with water, air dried and crystallized from dioxane to give compound 4. 
Ethyl 6-methyl-4-(10-oxo-4,6,7,8,9,10-hexahydropyrazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-3-yl)-2-thioxo-
1,2,3,4-tetrahydropyrimidine-5-carboxylate (5)  
A mixture of compound 2 (0.273 g, 0.001 mol), thiourea (0.076 g, 0.001 mol) and ethyl acetoacetate (0.13 mL, 
0.001 mol) in ethanol (10 mL) containing few drops of hydrochloric acid, was heated under reflux for 6h. The precipitated 
solid was filtered off, washed with water, air dried and crystallized from DMF/H2O to give compound 5 as brown crystals, 
yield 75%, mp > 300 ºC. IR (KBr) νmax/cm
-1
: 3421 (NH), 2932 (CHaliph.), 1699, 1683 (2C=O), 1616 (C=N), 1558 (C=C), 
1207 (C=S); 
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.27 (t, 3H, CH2CH3, J = 6.9 Hz), 1.79-1.80 (m, 4H, 2CH2), 2.08 
(s, 3H, CH3), 2.66 (t, 2H, CH2), 2.92 (t, 2H, CH2), 4.20 (q, 2H, CH2CH3, J = 6.9 Hz), 5.30 (d, 1H, pyrimidine-H4), 6.90 (s, 
1H, NH exchangeable with D2O), 7.07 (s, 1H, NH exchangeable with D2O), 7.24 (s, 1H, NH exchangeable with D2O), 8.26 
(s, 1H, pyrazole-H2); MS m/z (%): 444 [M
+
+1] (66), 443 [M
+
] (64), 393 (77), 306 (61), 268 (89), 208 (100), 183 (72), 158 
(60), 141 (64), 83 (54), 57 (38); Anal. Calcd for C20H21N5O3S2 (443.54): C, 54.16; H, 4.77; N, 15.79; S, 14.46. Found C, 
54.16; H, 4.78; N, 15.80; S, 14.46%. 
3-(5-Acetyl-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-yl)-6,7,8,9-tetrahydroprazolo[1,5-a][1]benzothieno[2,3-
d]pyrimidin-10(4H)-one (6)  
A mixture of compound 2 (0.273 g, 0.001 mol), thiourea (0.076 g, 0.001 mol) and acetylacetone (0.1 mL, 0.001 
mol) in absolute ethanol  (10 mL) containing few drops of hydrochloric acid, was heated under reflux for 4h. After cooling, 
the precipitated solid was filtered off, air dried and crystallized from ethanol to give compound 6 as brown crystals, yield 
69%, mp > 300 ºC. IR (KBr) νmax/cm
-1
: 3421-3223 (NH), 2934 (CHaliph.), 1700 (C=Oacetyl), 1661 (C=Oamide), 1609 (C=N), 
1560 (C=C), 1250 (C=S);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.80-1.90 (m, 4H, 2CH2), 2.09 (s, 3H, CH3), 2.70 (t, 
2H, CH2), 2.92 (t, 2H, CH2), 3.82 (s, 3H, CH3CO), 7.42 (d, 1H, pyrimidine-H4), 8.36 (s, 1H, pyrazole-H2), 8.49 (s, 1H, NH 
exchangeable with D2O), 8.51 (s, 1H, NH exchangeable with D2O), 9.93 (s, 1H, NH exchangeable with D2O); MS m/z (%): 
415 [M
+
+2] (10), 414 [M
+
+1] (14), 413 [M
+
] (10), 390 (18), 359 (16), 273 (100), 245 (39), 159 (15), 95 (25), 52 (37); Anal. 
Calcd for C19H19N5O2S2 (413.51): C, 55.19; H, 4.63; N, 16.94; S, 15.51. Found C, 55.20; H, 4.62; N, 16.94; S, 15.52%. 
  3-(7,7-Dimethyl-5-oxo-2-thioxo-1,2,3,4,5,6,7,8-octahydroquinazolin-4-yl)-6,7,8,9-tetrahydroprazolo[1,5-a][1] 
benzothieno[2,3-d]pyrimidin-10(4H)-one (7)  
A mixture of compound 2 (0.273 g, 0.001 mol), thiourea (0.076 g, 0.001 mol) and 5,5-dimethylcyclohexane-1,3-
dione (0.196 g, 0.014 mol) in absolute ethanol (10 mL) containing few drops of hydrochloric acid, was heated under reflux 
for 3h. After cooling, the precipitated solid was filtered off, air dried and crystallized from ethanol to give compound 7 as 
yellow crystals, yield 81%, mp 182-184 ºC. IR (KBr) νmax/cm
-1
: 3420-3155 (NH), 2937 (CHaliph.), 1705, 1653 (2C=O), 1617 
(C=N), 1540 (C=C), 1236 (C=S); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.01 (s, 6H, 2CH3), 1.78-1.80 (m, 4H, 2CH2), 
2.12 (s, 2H, CH2), 2.54 (s, 2H, CH2), 2.60 (t, 2H, CH2), 2.90 (t, 2H, CH2), 5.23 (d, 1H, pyrimidine-H4), 7.87 (s, 1H, 
pyrazole-H2), 8.12 (s, 1H, NH exchangeable with D2O), 8.58 (s, 1H, NH exchangeable with D2O), 9.08 (s, 1H, NH 
exchangeable with D2O); MS m/z (%): 453 [M
+
] (12), 452 [M
+
-1] (9), 385 (11), 290 (55), 273 (33), 220 (38), 164 (100), 140 
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(96), 84 (75), 69 (62), 55 (85); Anal. Calcd for C22H23N5O2S2 (453.58): C, 58.26; H, 5.11; N, 15.44; S, 14.14. Found C, 
58.26; H, 5.10; N, 15.44; S, 14.14%. 
2-Mercapto-6-oxo-4-(10-oxo-4,6,7,8,9,10-hexahydropyrazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-3-yl)-1,6-
dihydropyrimidine-5-carbonitrile (8)  
A mixture of compound 2 (0.273 g, 0.001 mol), thiourea (0.076 g, 0.001 mol) and ethyl cyanoacetate (0.11 mL, 
0.001 mol) in sodium ethoxide (0.023 g/Na in 10 mL EtOH), was stirred at room temperature overnight. The reaction 
mixture was poured onto ice/water. The precipitated solid was filtered off, washed with water, air dried and crystallized 
from DMF/H2O to give compound 8 as yellow crystals, yield 81%, mp > 300 ºC. IR (KBr) νmax/cm
-1
: 3424 (NH), 2961 
(CHaliph.), 2380 (SH), 2220 (C≡N), 1701, 1678 (2C=O), 1623 (C=N), 1591 (C=C); 
 1
H NMR spectrum (300 MHz, DMSO-d6) 
δ 1.23 (s, 1H, SH exchangeable with D2O), 1.79-1.81 (m, 4H, 2CH2), 2.70 (t, 2H, CH2), 2.91 (t, 2H, CH2), 8.25 (s, 1H, 
pyrazole-H2), 8.39 (s, 1H, NH exchangeable with D2O), 8.58 (s, 1H, NH exchangeable with D2O); MS m/z (%): 397 [M
+
+1] 
(29), 396 [M
+
] (34), 395 [M
+
-1] (5), 349 (28), 300 (24), 273 (33), 257 (41), 237 (39), 187 (31), 159 (39), 90 (25), 54 (100); 
Anal. Calcd for C17H12N6O2S2 (396.44): C, 51.50; H, 3.05; N, 21.20; S, 16.18. Found C, 51.50; H, 3.05; N, 21.20; S, 
16.18%. 
10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-carbaldehyde hydrazone (9)  
A mixture of compound  2 (0.546 g, 0.002 mol) and hydrazine hydrate  (0.1 mL, 0.002 mol), in DMF (10 mL) 
containing few drops of triethylamine, was heated under reflux for 4h. After cooling, the reaction mixture was poured onto 
ice/water. The precipitated solid was filtered off, washed with water, air dried and crystallized from DMF/EtOH to give 
compound 9 as violet crystals, yield 73%, mp > 300 ºC. IR (KBr) νmax/cm
-1
: 3340-3197 (NH2, NH), 3094 (CHarom.), 2931 
(CHaliph.), 1670 (C=O), 1607 (C=N), 1570 (C=C); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.80-1.91 (m, 4H, 2CH2), 2.73 
(t, 2H, CH2), 2.89 (t, 2H, CH2), 3.36 (s, 2H, NH2 exchangeable with D2O), 8.11 (s, 1H, pyrazole-H2), 8.84 (s, 1H, CH=N), 
11.51 (bs, 1H, NH exchangeable with D2O); MS m/z (%): 288 [M
+
+1] (54), 287 [M
+
] (58),  257 (69), 237 (59), 211 (61), 186 
(58), 103 (62), 69 (100), 55 (67); Anal. Calcd for C13H13N5OS (287.34): C, 54.34; H, 4.56; N, 24.37; S, 11.16. Found C, 
54.34; H, 4.56; N, 24.38; S, 11.16%. 
10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-carbaldehyde  
N-phenyl thiosemicarbazone (10)  
A mixture of compound 9 (0.287 g, 0.001 mol) and phenyl isothiocyanate  (0.135 mL, 0.001 mol), in DMF (10 mL) 
containing catalytic amount of piperidine , was heated under reflux for 4h. After cooling, the reaction mixture was poured 
onto ice/water. The precipitated solid was filtered off, washed with water, air dried and crystallized from DMF to give 
compound 10 as brown crystals, yield 69%, mp 245-247 ºC. IR (KBr) νmax/cm
-1
: 3441 (NH), 3054 (CHarom.), 2929 (CHaliph.), 
1647 (C=O), 1556 (C=N), 1532 (C=C), 1181 (C=S); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.79-1.90 (m, 4H, 2CH2), 
2.73 (t, 2H, CH2), 2.88 (t, 2H, CH2), 6.93-8.37 (m, 5H, Ar-H), 8.42 (s, 1H, pyrazole-H2), 8.66 (s, 1H, NH exchangeable with 
D2O), 8.88 (s, 1H, NH exchangeable with D2O), 9.90 (s, 1H, CH=N), 12.12 (s, 1H, NH exchangeable with D2O); MS m/z 
(%): 424 [M
+
+2] (8), 423 [M
+
+1] (2), 422 [M
+
] (11), 391 (12), 317 (11), 245 (11), 204 (14), 135 (27), 93 (100), 77 (47); Anal. 
Calcd for C20H18N6OS2 (422.53): C, 56.85; H, 4.29; N, 19.89; S, 15.18. Found C, 56.86; H, 4.30; N, 19.88; S, 15.18%. 
1-{[(10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-3-yl)methylene]amino}-3-phenyl-2-
thioxoimidazoline-4,5-dione (11) 
A mixture of compound 10 (0.422 g, 0.001 mol) and oxalyl chloride (0.09 mL, 0.001 mol), in DMF (10 mL) 
containing few drops of triethylamine, was heated under reflux for 4h. After cooling, the reaction mixture was poured onto 
ice/water. The precipitated solid was filtered off, washed with water, air dried and crystallized from DMF-H2O to give 
compound 11 as violet crystals, yield 72%, mp > 300ºC. IR (KBr) νmax/cm
-1
: 3419 (NH), 3055 (CHarom.), 2931 (CHaliph.), 
1641 (C=O), 1530 (C=C), 1247 (C=S);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.79-1.82 (m, 4H, 2CH2), 2.72 (t, 2H, 
CH2), 2.88 (t, 2H, CH2), 7.07-7.30 (m, 6H, Ar-H and CH=N), 8.20 (s, 1H, pyrazole-H2), 8.31 (s, 1H, NH exchangeable with 
D2O); Anal. Calcd for C22H16N6O3S2 (476.53): C, 55.45; H, 3.38; N, 17.64; S, 13.46; Found 55.44; H 3.38; N 17.64; S 
13.46%. 
10-Oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-carbaldehyde thiosemicarbazone 
(12)  
A mixture of compound 2 (0.273 g, 0.001 mol) and thiosemicarbazide (0.091 g, 0.001 mol) in glacial acetic acid 
(10 mL), was heated under reflux for 3h. After cooling, the reaction mixture was poured onto ice/water. The precipitated 
solid was filtered off, washed with water, air dried and crystallized from ethanol to give compound 12 as red crystals, yield 
74%, mp 244-246 ºC. IR (KBr) νmax/cm
-1
: 3445-3300 (NH2, NH), 3054 (CHarom.), 2933 (CHaliph.), 1683 (C=O), 1627 (C=N), 
1569 (C=C), 1200 (C=S); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.80-1.83 (m, 4H, 2CH2), 2.69 (t, 2H, CH2), 2.89 (t, 
2H, CH2), 3.47 (bs, 2H, NH2 exchangeable with D2O), 8.18 (s, 1H, pyrazole-H2), 8.36 (s, 1H, NH exchangeable with D2O), 
9.77 (s, 1H, CH=N), 11.22 (s, 1H, NH exchangeable with D2O); MS m/z (%): 345 [M
+
-1] (15), 344 [M
+
-2] (16), 320 (16), 
290 (18), 250 (23), 236 (29) 116 (25), 76 (95), 59 (100); Anal. Calcd for C14H14N6OS2 (346.43): C, 48.54; H, 4.07; N, 
24.26; S, 18.51. Found C, 48.54; H, 4.08; N, 24.26; S, 18.50%. 
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3-{[(5-Oxo-4,5-dihydro-1H-pyrazol-3-yl)imino]methyl}-6,7,8,9-tetrahydroprazolo[1,5-a][1]benzothieno[2,3-d] 
pyrimidin-10(4H)-one (13)  
A mixture of compound 2 (0.273 g, 0.001 mol) and 5-amino-2,4-dihydro-3-pyrazol-3-one (0.099 g, 0.001 mol) in 
absolute ethanol (10 mL) containing few drops of  glacial acetic acid, was heated under reflux for 2h. After cooling, the 
precipitated solid was filtered off, washed with cold ethanol, air dried and crystallized from DMF/H2O to give compound 13 
as red crystals, yield 76%, mp > 300 ºC. IR (KBr) νmax/cm
-1
: 3373 (NH), 3089 (CHarom.), 2929 (CHaliph.), 1660 (2C=O), 1608 
(C=N), 1550 (C=C); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.77-1.79 (m, 4H, 2CH2), 2.70 (t, 2H, CH2), 2.89 (t, 2H, 
CH2), 4.83 (s, 2H, CH2), 7.56 (s, 1H, pyrazole-H2), 7.97 (s, 1H, CH=N), 8.14 (s, 1H, NH exchangeable with D2O), 9.52 (s, 
1H, NH exchangeable with D2O); MS m/z (%): 355 [M
+
+1] (33), 354 [M
+
] (13), 340 (26), 250 (34), 239 (35), 100 (42), 80 
(100), 64 (78), 51 (26); Anal. Calcd for C16H14N6O2S (354.39): C, 54.23; H, 3.98; N, 23.71; S, 9.05. Found C, 54.22; H, 
3.98; N, 23.70; S, 9.04%. 
3-[(3-Amino-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)methyl]-6,7,8,9-tetrahydroprazolo[1,5-a][1]benzothieno[2,3-d] 
pyrimidin-10(4H)-one (14)  
Method A. A mixture of compound  2 (0.273 g, 0.001 mol) and 5-amino-2,4-dihydro-3-pyrazol-3-one (0.099 g, 
0.001 mmol) in absolute ethanol (10 mL) containing catalytic amount of triethylamine, was heated under reflux for 2h. After 
cooling, the precipitated solid was filtered off, air dried and crystallized from ethanol to give compound 14 as red crystals, 
yield 74%, mp 237-239 ºC; IR (KBr) νmax/cm
-1
: 3455, 3423, 3312, 3223 (NH2, NH), 3026 (CHarom.), 2944 (CHaliph.), 1672, 
1647 (2C=O), 1585 (C=N), 1530 (C=C); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.78-1.80 (m, 4H, 2CH2), 2.65 (t, 2H, 
CH2), 2.93 (t, 2H, CH2), 5.22 (bs, 2H, NH2 exchangeable with D2O), 7.66 (s, 1H, pyrazole-H2), 9.56 (s, 1H, CH=), 9.65 (s, 
2H, 2NH exchangeable with D2O); MS m/z (%): 356 [M
+
+2] (1), 355 [M
+
+1] (2), 354 [M
+
] (8), 340 (5), 323 (3), 245 (18), 
230 (8), 217 (14), 191 (5), 99 (80), 84 (100), 64 (93), 56 (58); Anal. Calcd for C16H14N6O2S (354.39): C, 54.23; H, 3.98; N, 
23.71; S, 9.05. Found C, 54.23; H, 3.98; N, 23.71; S, 9.05%. 
Method B. Compound 15 (0.354 g, 0.001 mol) was fused for 1 h, then allowed to cool and diluted with water. The solid 
was filtered off and recrystallized from ethanol to give compound 14. 
2-Cyano-3-(10-oxo-4,6,7,8,9,10-hexahydropyrazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-3-yl) acrylohydrazide (15)  
A mixture of compound  2 (0.273 g, 0.001 mol), cyanoacetohydrazide (0.099 g, 0.001 mol), in ethanol (10 mL) 
containing few drops of triethylamine, was stirred vigorously for 3h at room temperature, then left overnight. The 
precipitated solid was filtered off, washed with cold ethanol, air dried and crystallized from DMF/H2O to give compound 15 
as red crystals (0.212 g, yield 78%): mp > 300 ºC; IR (KBr) νmax/cm
-1
: 3424-3188 (NH2, NH), 3031 (CHarom.), 2930 (CHaliph.), 
2257 (C≡N), 1675, 1636 (2C=O), 1615 (C=N), 1575 (C=C);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.76-1.78 (m, 4H, 
2CH2), 2.63 (t, 2H, CH2), 2.90 (t, 2H, CH2), 5.63 (s, 2H, NH2 exchangeable with D2O), 7.21 (s, 1H, CH=), 7.99 (s, 1H, 
pyrazole-H2), 9.97 (s, 1H, NH exchangeable with D2O), 11.24 (s, 1H, NH exchangeable with D2O); MS m/z (%): 355 
[M
+
+1] (67), 354 [M
+
] (71), 325 (74), 303 (83), 274 (63), 271 (77), 231 (66), 191 (90) 159 (100), 117 (58); Anal. Calcd for 
C16H14N6O2S (354.38): C, 54.23; H, 3.98; N, 23.71; S, 9.05. Found C, 54.24; H, 3.98; N, 23.72; S, 9.06%. 
2-(5-Mercapto-1,3,4-oxadiazol-2-yl)-3-(10-oxo-4,6,7,8,9,10-hexahydropyrazolo[1,5-a][1]benzothieno[2,3-d]pyrimidin-
3-yl)acrylonitrile (16)  
A mixture of compound 15 (0.354 g, 0.001 mol) and carbon disulphide (0.06 mL, 0.001 mole) in ethanolic 
potassium hydroxide (2%, 15 ml) was heated under reflux for 4h. After cooling, the reaction mixture was poured onto 
ice/water and neutralized with conc. HCl. The precipitated solid was filtered off, washed with water, air dried and 
crystallized from DMF-H2O to give compound 16 as red crystals, yield 74%, mp > 300 ºC. IR (KBr) νmax/cm
-1
: 3331, 3233 
(NH), 2934 (CHaliph.), 2350 (SH), 2220 (C≡N), 1661 (C=O), 1601 (C=N), 1562 (C=C);
 1
H NMR spectrum (300 MHz, DMSO-
d6) δ 1.23 (s, 1H, SH exchangeable with D2O), 1.79-1.81 (m, 4H, 2CH2), 2.70 (t, 2H, CH2), 2.94 (t, 2H, CH2), 8.15 (s, 1H, 
CH=), 8.39 (s, 1H, pyrazole-H2), 9.82 (s, 1H, NH exchangeable with D2O); Anal. Calcd for C17H12N6O2S2 (396.44): C, 
51.50; H, 3.05; N, 21.20; S, 16.18. Found C, 51.52; H, 3.04; N, 21.22; S, 16.18%. 
 3-[3-(5,6-Diphenyl-3-oxo-2,3-dihydropyridazin-4-yl)-3-oxoprop-1-en-1-yl]-6,7,8,9-tetrahydropyrazolo[1,5-a][1] 
benzothieno[2,3-d]pyrimidin-10(4H)-one (18)  
A mixture of compound 2 (0.273 g, 0.001 mol) and 4-acetyl-5,6-diphenylpyridazin-3(2H)-one 17 (0.29 g, 0.001 
mol) in ethanol (10 mL) containing catalytic amount of piperidine, was heated under reflux for 4h. After cooling, the 
precipitated solid was filtered off, air dried and crystallized from ethanol to give compound 18 as brown crystals, yield 82%, 
mp 196-198 ºC. IR (KBr) νmax/cm
-1
: 3446 (NH), 3051 (CHarom.), 2934 (CHaliph.), 1670, 1653, 1647 (3C=O), 1600 (C=N), 
1559 (C=C);
 1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.78-1.80 (m, 4H, 2CH2), 2.72 (t, 2H, CH2), 2.93 (t, 2H, CH2), 7.10 
(d, 1H, Hα), 7.17-7.55 (m, 10H, Ar-H), 7.66 (d, 1H, Hβ), 7.85 (s, 1H, NH exchangeable with D2O), 7.87 (s, 1H, NH 
exchangeable with D2O), 8.44 (s, 1H, pyrazole-H2); MS m/z (%): 545 [M
+
] (35), 468 (29), 373 (25), 300 (73), 216 (35), 149 
(29), 105 (100), 77 (95), 69 (43), 55 (41); Anal. Calcd for C31H23N5O3S (545.61): C, 68.24; H, 4.25; N, 12.84; S, 5.88. 
Found C, 68.22; H, 4.25; N, 12.84; S, 5.88%. 
2-Amino-6-(5,6-diphenyl-3-oxo-2,3-dihydropyridazin-4-yl)-4-(10-oxo-4,6,7,8,9,10-hexahydropyrazolo[1,5-a][1] 
benzothieno[2,3-d]pyrimidin-3-yl)-4H-pyran-3-carbonitrile (19)  
A mixture of compound 18 (0.545 g, 0.001 mol) and malnonitrile (0.066 g, 0.001 mol) in pyridine (10 mL), was 
heated under reflux for 3h. After cooling, the reaction mixture was poured onto ice/water and neutralized with conc. HCl. 
The precipitated solid was filtered off, air dried and crystallized from ethanol to give compound 19 as brown crystals, yield 
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81%, mp 107-109 ºC. IR (KBr) νmax/cm
-1
: 3423-3200 (NH2, NH), 3050 (CHarom.), 2930 (CHaliph.), 2215 (C≡N), 1637 (2C=O), 
1600 (C=N), 1571 (C=C); 
1
H NMR spectrum (300 MHz, DMSO-d6) δ 1.80-1.83 (m, 4H, 2CH2), 2.73 (t, 2H, CH2), 2.89 (t, 
2H, CH2), 4.45 (s, 2H, NH2 exchangeable with D2O), 7.12-7.39 (m, 10H, Ar-H), 7.94 (d, 1H, pyran-H4), 8.36 (s, 1H, 
pyrazole-H2), 8.41 (d, 1H, pyran-H5), 8.86 (s, 2H, NH exchangeable with D2O); MS m/z (%): 613 [M
+
+2] (2), 612 [M
+
+1] 
(14), 611 [M
+
] (5), 567 (20), 482 (17), 414 (19), 365 (18), 276 (24), 225 (20), 105 (19), 91 (64), 75 (100), 68 (62); Anal. 
Calcd for C34H25N7O3S (611.67): C, 66.76; H, 4.12; N, 16.03; S, 5.24. Found C, 66.76; H, 4.12; N, 16.02; S, 5.24%. 
2-Amino-6-(5,6-diphenyl-3-oxo-2,3-dihydropyridazin-4-yl)-4-(10-oxo-4,6,7,8,9,10-hexahydropyrazolo[1,5-a][1] 
benzothieno[2,3-d]pyrimidin-3-yl)pyridine-3-carbonitrile (20)  
A mixture of compound 18 (0.545 g, 0.001 mol), malnonitrile (0.066 g, 0.001 mol) and ammonium acetate (0.08 
g, 0.001 mol) in ethanol (10 mL), was heated under reflux for 3h. The precipitated solid was filtered off, washed with water, 
air dried and crystallized from dioxane to give compound 20 as brown crystals, yield 70%, mp > 300ºC. IR (KBr) νmax/cm
-1
: 
3350-3200 (NH2, NH), 3090 (CHarom.), 2980 (CHaliph.), 2211 (C≡N), 1670 (2C=O), 1616 (C=N), 1560 (C=C);
 1
H NMR 
spectrum (300 MHz, DMSO-d6) δ 1.82-1.89 (m, 4H, 2CH2), 2.70 (t, 2H, CH2), 2.92 (t, 2H, CH2), 5.40 (s, 2H, NH2 
exchangeable with D2O), 7.04 (s, 1H, pyridine-H5), 7.22-7.60 (m, 10H, Ar-H), 8.36 (s, 1H, pyrazole-H2), 8.80 (s, 2H, NH 
exchangeable with D2O), 8.89 (s, 2H, NH exchangeable with D2O); Anal. Calcd for C34H24N8O2S (608.67): C, 67.09; H, 
3.97; N, 18.41; S, 5.27. Found C, 67.08; H, 3.98; N, 18.40; S, 5.26%.  
  
 CONCLUSIONS  
In conclusion 10-oxo-4,6,7,8,9,10-hexahydroprazolo[1,5-a][1]benzothieno[2,3-d]pyrimidine-3-carbaldehyde (2) has proved 
to be a versatile precursor for the synthesis of some polycyclic heterocycles possessing the 
pyrazolobenzothienopyrimidine ring. The synthesized compounds were screened for their antimicrobial activity.  
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